Clinical Trial Update: A Umbrella Study in R/R PTCL Guided by Molecular Subtypes [Phase 1, Phase 2]

View source ↗

Summary

An umbrella study in relapsed/refractory peripheral T cell lymphoma guided by molecular subtypes is described across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN